|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 4 (February 15), 2000:
pp. 1237-1248
Quantitative assessment of retroviral transfer of the human
multidrug resistance 1 gene to human mobilized peripheral blood
progenitor cells engrafted in nonobese diabetic/severe combined
immunodeficient mice
B. Schiedlmeier,
K. Kühlcke,
H. G. Eckert,
C. Baum,
W. J. Zeller, and
S. Fruehauf
From the German Cancer Research Center, Department D 0200, Heidelberg, Germany; EUFETS GmbH, Idar-Oberstein, Germany;
Heinrich-Pette-Institut, Hamburg, Germany; and the Department of
Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
Mobilized peripheral blood progenitor cells (PBPC) are a potential
target for the retrovirus-mediated transfer of cytostatic drug-resistance genes. We analyzed nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse-repopulating CD34+ PBPC from patients with cancer after retroviral transduction in various cytokine
combinations with the hybrid vector SF-MDR, which is based on the
Friend mink cell focus-forming/murine embryonic stem-cell virus and
carries the human multidrug resistance 1 (MDR1) gene. Five to
13 weeks after transplantation of CD34+ PBPC into NOD/SCID mice
(n = 84), a cell dose-dependent multilineage engraftment of human
leukocytes up to an average of 33% was observed. The SF-MDR provirus
was detected in the bone marrow (BM) and in its granulocyte fractions
in 96% and 72%, respectively, of chimeric NOD/SCID mice. SF-MDR
provirus integration assessed by quantitative real-time polymerase
chain reaction (PCR) was optimal in the presence of Flt-3
ligand/thrombopoietin/stem-cell factor, resulting in a 6-fold (24% ± 5% [mean ± SE]) higher average proportion of gene-marked human
cells in NOD/SCID mice than that achieved with IL-3 alone (P < .01). A population of clearly
rhodamine-123dull human myeloid progeny cells could be
isolated from BM samples from chimeric NOD/SCID mice. On the basis of
PCR and rhodamine-123 efflux data, up to 18% ± 4% of transduced
cells were calculated to express the transgene. Our data suggest that
the NOD/SCID model provides a valid assay for estimating the
gene-transfer efficiency to repopulating human PBPC that may be
achievable in clinical autologous transplantation. P-glycoprotein
expression sufficient to prevent marrow aplasia in vivo may be obtained
with this SF-MDR vector and an optimized transduction protocol.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Schaich, L. Kestel, M. Pfirrmann, K. Robel, T. Illmer, M. Kramer, C. Dill, G. Ehninger, G. Schackert, and D. Krex
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
Ann. Onc.,
January 1, 2009;
20(1):
175 - 181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Bleier, P. Maier, H. Allgayer, F. Wenz, W. J. Zeller, S. Fruehauf, and S. Laufs
Multiple Displacement Amplification Enables Large-Scale Clonal Analysis following Retroviral Gene Therapy
J. Virol.,
March 1, 2008;
82(5):
2448 - 2455.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Bozorgmehr, S. Laufs, S. E. Sellers, I. Roeder, W. J. Zeller, C. E. Dunbar, and S. Fruehauf
No Evidence of Clonal Dominance in Primates up to 4 Years Following Transplantation of Multidrug Resistance 1 Retrovirally Transduced Long-Term Repopulating Cells
Stem Cells,
October 1, 2007;
25(10):
2610 - 2618.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Wagner, S. Laufs, J. Blake, C. Schwager, X. Wu, J. W. Zeller, A. D. Ho, and S. Fruehauf
Retroviral Integration Sites Correlate with Expressed Genes in Hematopoietic Stem Cells
Stem Cells,
September 1, 2005;
23(8):
1050 - 1058.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Wagner, A. Ansorge, U. Wirkner, V. Eckstein, C. Schwager, J. Blake, K. Miesala, J. Selig, R. Saffrich, W. Ansorge, et al.
Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis
Blood,
August 1, 2004;
104(3):
675 - 686.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Z. Nagy, S. Laufs, B. Gentner, S. Naundorf, K. Kuehlcke, J. Topaly, E. C. Buss, W. J. Zeller, and S. Fruehauf
Clonal Analysis of Individual Marrow-Repopulating Cells after Experimental Peripheral Blood Progenitor Cell Transplantation
Stem Cells,
July 1, 2004;
22(4):
570 - 579.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Steinbach, S. Wittig, G. Cario, S. Viehmann, A. Mueller, B. Gruhn, R. Haefer, F. Zintl, and A. Sauerbrey
The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype
Blood,
December 15, 2003;
102(13):
4493 - 4498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Brenner, N. L. Whiting-Theobald, G. F. Linton, K. L. Holmes, M. Anderson-Cohen, P. F. Kelly, E. F. Vanin, A. M. Pilon, D. M. Bodine, M. E. Horwitz, et al.
Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/{beta}2-microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells
Blood,
October 15, 2003;
102(8):
2789 - 2797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Laufs, B. Gentner, K. Z. Nagy, A. Jauch, A. Benner, S. Naundorf, K. Kuehlcke, B. Schiedlmeier, A. D. Ho, W. J. Zeller, et al.
Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells
Blood,
March 15, 2003;
101(6):
2191 - 2198.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Roesler, S. Brenner, A. A. Bukovsky, N. Whiting-Theobald, T. Dull, M. Kelly, C. I. Civin, and H. L. Malech
Third-generation, self-inactivating gp91phox lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease
Blood,
December 15, 2002;
100(13):
4381 - 4390.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Illmer, U. S. Schuler, C. Thiede, U. I. Schwarz, R. B. Kim, S. Gotthard, D. Freund, U. Schakel, G. Ehninger, and M. Schaich
MDR1 Gene Polymorphisms Affect Therapy Outcome in Acute Myeloid Leukemia Patients
Cancer Res.,
September 1, 2002;
62(17):
4955 - 4962.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F Xue, T Takahara, Y Yata, M Minemura, C Y Morioka, S Takahara, E Yamato, K Dono, and A Watanabe
Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation
Gut,
April 1, 2002;
50(4):
558 - 562.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Scherr, K. Battmer, U. Blomer, B. Schiedlmeier, A. Ganser, M. Grez, and M. Eder
Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells
Blood,
January 15, 2002;
99(2):
709 - 712.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Gatlin, M. W. Melkus, A. Padgett, P. F. Kelly, and J. V. Garcia
Engraftment of NOD/SCID Mice with Human CD34+ Cells Transduced by Concentrated Oncoretroviral Vector Particles Pseudotyped with the Feline Endogenous Retrovirus (RD114) Envelope Protein
J. Virol.,
October 15, 2001;
75(20):
9995 - 9999.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. An, S. K. P. Kung, A. Bonifacino, R. P. Wersto, M. E. Metzger, B. A. Agricola, S. H. Mao, I. S. Y. Chen, and R. E. Donahue
Lentivirus Vector-Mediated Hematopoietic Stem Cell Gene Transfer of Common Gamma-Chain Cytokine Receptor in Rhesus Macaques
J. Virol.,
April 15, 2001;
75(8):
3547 - 3555.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
L. E. Perez, H. M. Rinder, C. Wang, J. B. Tracey, N. Maun, and D. S. Krause
Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production
Blood,
March 15, 2001;
97(6):
1635 - 1643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rovira, M. De Angioletti, O. Camacho-Vanegas, D. Liu, V. Rosti, H. F. Gallardo, R. Notaro, M. Sadelain, and L. Luzzatto
Stable in vivo expression of glucose-6-phosphate dehydrogenase (G6PD) and rescue of G6PD deficiency in stem cells by gene transfer
Blood,
December 15, 2000;
96(13):
4111 - 4117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Williams, A. W. Nienhuis, R. G. Hawley, and F. O. Smith
Gene Therapy 2000
Hematology,
January 1, 2000;
2000(1):
376 - 393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
